Stuart and Sorenson say proximity to scientific and technology hubs and finance centers affect biotech IPOs. Due to access to resources and networks, biotech businesses near universities and research organizations were more likely to go public. Biotech businesses in big cities with a lot of venture capital firms and investment banks were more likely to go public because they had access to the funding they needed to expand. The authors believe that closeness to scientific, technical, and financial hubs is vital to a biotech business going public. 